Michael Gibertini Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael Gibertini.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael Gibertini. Michael Gibertini is in INC Research Holdings, Inc. ($INCR) and Chief Operating Officer in INC Research Holdings, Inc. ($INCR) and President Clinical Development in INC Research Holdings, Inc. ($INCR).

Latest Insider Trading Transactions of Michael Gibertini

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 02 2017INCRINC Research Holdi ...Gibertini MichaelOption ExerciseM0.0016,50000
Aug 02 2017INCRINC Research Holdi ...Gibertini MichaelOption ExerciseM0.0015,85100
Aug 02 2017INCRINC Research Holdi ...Gibertini MichaelBuyM0.0011,000078,36067.4 K to 78.4 K (+16.33 %)
Aug 02 2017INCRINC Research Holdi ...Gibertini MichaelBuyM0.0010,567067,36056.8 K to 67.4 K (+18.61 %)
Jul 03 2017INCRINC Research Holdi ...Gibertini MichaelChief Operating Off ...Payment of ExerciseF58.5057633,69656,79357.4 K to 56.8 K (-1.00 %)
Jan 30 2017INCRINC Research Holdi ...Gibertini MichaelChief Operating Off ...Option ExerciseA0.0015,851015,851
Jan 30 2017INCRINC Research Holdi ...Gibertini MichaelChief Operating Off ...GrantA0.0010,567057,36946.8 K to 57.4 K (+22.58 %)
Jan 20 2017INCRINC Research Holdi ...Gibertini MichaelChief Operating Off ...Payment of ExerciseF50.5583742,31046,80247.6 K to 46.8 K (-1.76 %)
Sep 16 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...GrantA0.0029,110047,63918.5 K to 47.6 K (+157.11 %)
Jul 01 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Payment of ExerciseF38.1388333,66918,52919.4 K to 18.5 K (-4.55 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM16.0617,752285,09741,419
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM10.5714,628154,6189,750
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.45153,7161,298,90051,928
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.841,47664,71219,41220.9 K to 19.4 K (-7.07 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.0526,3941,136,26220,88847.3 K to 20.9 K (-55.82 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.761,10048,13247,28248.4 K to 47.3 K (-2.27 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.0516,652716,85948,38265 K to 48.4 K (-25.61 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM16.0617,752285,09765,03447.3 K to 65 K (+37.54 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.8287738,42747,28248.2 K to 47.3 K (-1.82 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.1913,751593,83848,15961.9 K to 48.2 K (-22.21 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM10.5714,628154,61861,91047.3 K to 61.9 K (+30.94 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.839,034395,97647,28256.3 K to 47.3 K (-16.04 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS43.05144,6826,228,96556,316201 K to 56.3 K (-71.98 %)
Jun 07 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.45153,7161,298,900200,99847.3 K to 201 K (+325.10 %)
Apr 04 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.459,00076,050205,644
Apr 04 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS40.789,000367,03847,28256.3 K to 47.3 K (-15.99 %)
Apr 04 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.459,00076,05056,28247.3 K to 56.3 K (+19.03 %)
Mar 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.459,00076,050214,644
Mar 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS39.859,000358,67747,28256.3 K to 47.3 K (-15.99 %)
Mar 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.459,00076,05056,28247.3 K to 56.3 K (+19.03 %)
Feb 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.459,00076,050223,644
Feb 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS41.561,00041,56047,28248.3 K to 47.3 K (-2.07 %)
Feb 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS40.458,000323,59248,28256.3 K to 48.3 K (-14.21 %)
Feb 02 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.459,00076,05056,28247.3 K to 56.3 K (+19.03 %)
Jan 21 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseA0.0016,500016,500
Jan 21 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseA42.884,889209,6404,889
Jan 21 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...GrantA0.0011,000047,28236.3 K to 47.3 K (+30.32 %)
Jan 06 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.459,00076,050232,644
Jan 06 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS47.523,100147,30336,28239.4 K to 36.3 K (-7.87 %)
Jan 06 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS46.475,900274,19139,38245.3 K to 39.4 K (-13.03 %)
Jan 06 2016INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.459,00076,05045,28236.3 K to 45.3 K (+24.81 %)
Dec 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.459,00076,050241,644
Dec 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS47.431,38565,68936,28237.7 K to 36.3 K (-3.68 %)
Dec 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS46.655,200242,59037,66742.9 K to 37.7 K (-12.13 %)
Dec 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS45.712,415110,38242,86745.3 K to 42.9 K (-5.33 %)
Dec 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.459,00076,05045,28236.3 K to 45.3 K (+24.81 %)
Nov 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseM8.459,00076,050250,644
Nov 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS41.709,000375,30036,28245.3 K to 36.3 K (-19.88 %)
Nov 03 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...BuyM8.459,00076,05045,28236.3 K to 45.3 K (+24.81 %)
Jul 02 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...Option ExerciseA40.1216,825675,01916,825
Jul 02 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...GrantA0.008,412036,28227.9 K to 36.3 K (+30.18 %)
May 11 2015INCRINC Research Holdi ...Gibertini MichaelPresident Clinical ...SellS29.6850,0001,484,00027,87077.9 K to 27.9 K (-64.21 %)

Page:   1